Stay updated with breaking news from Normalizing Timing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In 2021, a Northwestern University-led research team received a Defense Advanced Research Projects Agency (DARPA) contract worth up to $33 million to develop an implantable "living pharmacy" to control the human body's sleep/wake cycles.
<p>Researchers have developed a novel device that produces oxygen inside of a "living pharmacy" implant in order to keep cells alive inside the self-contained device. The device produses oxygen through a smart, energy-efficient version of water splitting. In new experiments, the novel device kept cells (70-80%) alive for close to a month in low oxygen conditions in vitro, or weeks in vivo. Without ecO<sub>2</sub>, only about 20% of cells were alive after 10 days, but the researchers hypothesize that the cells would lose their abili...
It involves using an implant in the brain. When Blackrock co-founders Marcus Gerhardt and Florian Solzbacher were teenagers, they attended a private preparatory boarding school together in repurposed military housing in a castle near the ocean in Wales. One day teenage Gerhardt told teenage Solzbacher that he had no idea what he wanted to do with his life. Solzbacher responded with singular purpose that he knew exactly what he wanted to do. "'I want to create the connection between artificial and natural limb," he said. He went on to build his entire career around that vision, and many years ...
July 6, 2021 By Deborah Borfitz July 6, 2021 | A trio of universities are putting their heads together to engineer a wirelessly controlled bioelectronic implant intended to help soldiers adapt to new time zones or drastic changes in their work schedules by releasing peptide-based therapies to harmonize their central and peripheral circadian clocks. The solicitation came from the Defense Advanced Research Projects Agency (DARPA) and the timeline is ambitious, with a first-in-human safety study expected to begin by 2025, according to Jonathan Rivnay, principal investigator of the p...
Implantable 'living pharmacy' will halve jet lag recovery time Ian Randall For Mailonline © Provided by Daily Mail MailOnline logo An implantable 'living pharmacy' that may be able to halve the time it takes to recover from jet lag is being developed by researchers from Illinois. Northwestern University experts have signed a $33 million (£23.3 million) contract with the US Defense Advanced Research Projects Agency to develop the device. Combining synthetic biology with electronics, the implant would contain engineered cells which produce the same peptides the body uses to...